Literature DB >> 26238946

Association of genetic variants with dyslipidemia.

Shintaro Abe1, Fumitaka Tokoro1, Reiko Matsuoka1, Masazumi Arai1, Toshiyuki Noda1, Sachiro Watanabe1, Hideki Horibe2, Tetsuo Fujimaki3, Mitsutoshi Oguri4, Kimihiko Kato5, Shinya Minatoguchi6, Yoshiji Yamada7.   

Abstract

Although genetic variants, which regulate lipid metabolism, have been extensively investigated in Caucasian populations, the genes, which confer susceptibility to dyslipidemia in Japanese individuals, remain to be elucidated. The aim of the present study was to examine a possible association among hypertriglyceridemia, hypo‑high density lipoprotein (HDL)‑cholesterolemia or hyper‑low density lipoprotein (LDL)‑cholesterolemia in Japanese individuals with 29 polymorphisms observed to confer susceptibility for coronary heart disease. This was performed through meta‑analyses of genome‑wide association studies in Caucasian populations. The study population comprised 2,354 individuals with dyslipidemia (hypertriglyceridemia, hypo‑HDL‑cholesterolemia or hyper‑LDL‑cholesterolemia) and 3,106 control individuals. To compensate for multiple comparisons of genotypes, a false discovery rate (FDR) of <0.05 was adopted to determine the statistical significance of the associations. Comparisons of allele frequencies using the χ2 test revealed that rs964184 of zinc finger gene (ZPR1; FDR=2.1x10‑7), rs4845625 of interleukin 6 receptor (IL6R; FDR=0.032), rs46522 of ubiquitin‑conjugating enzyme E2Z gene (UBE2Z; FDR=0.032) and rs17514846 of furin (FDR=0.041) were significantly associated with hypertriglyceridemia. The χ2 test revealed that rs599839 of proline/serine‑rich coiled‑coil 1 (PSRC1; FDR=0.004) and rs2075650 of translocase of outer mitochondrial membrane 40 homolog (TOMM40; FDR=0.004) were significantly associated with hyper‑LDL‑cholesterolemia. Multivariate logistic regression analysis with adjustment for age, gender and body mass index revealed that rs964184 of ZPR1 (P=5.1x10‑7; odds ratio, 1.37; dominant model), rs4845625 of IL6R (P=0.0019, odds ratio, 1.25; dominant model) and rs46522 of UBE2Z (P=0.0039, odds ratio, 1.19; dominant model) were significantly associated with hypertriglyceridemia, and that rs599839 of PSRC1 (P=0.0004, odds ratio, 0.70; dominant model) and rs2075650 of TOMM40 (P=0.0004, odds ratio, 1.43; dominant model) were significantly associated with hyper‑LDL‑cholesterolemia. Therefore, ZPR1, IL6R, and UBE2Z may be susceptibility loci for hypertriglyceridemia, whereas PSRC1 and TOMM40 may be such loci for hyper-LDL-cholesterolemia in Japanese individuals.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26238946     DOI: 10.3892/mmr.2015.4081

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  12 in total

1.  Association of genetic variants with atrial fibrillation.

Authors:  Yuichiro Yamase; Kimihiko Kato; Hideki Horibe; Chikara Ueyama; Tetsuo Fujimaki; Mitsutoshi Oguri; Masazumi Arai; Sachiro Watanabe; Toyoaki Murohara; Yoshiji Yamada
Journal:  Biomed Rep       Date:  2015-12-02

2.  A Genetic Variant in Proline and Serine Rich Coiled-Coil 1 Gene Is Associated with the Risk of Cardiovascular Disease.

Authors:  Mohammad Sadegh Khorrami; Fatemeh Sadabadi; Alireza Pasdar; Hamide Safarian-Bana; Forouzan Amerizadeh; Habibollah Esmaeily; Mohsen Moohebati; Alireza Heidari-Bakavoli; Gordon Ferns; Majid Ghayour-Mobarhan; Amir Avan
Journal:  Rep Biochem Mol Biol       Date:  2022-01

3.  Hidden heterogeneity in Alzheimer's disease: Insights from genetic association studies and other analyses.

Authors:  Anatoliy I Yashin; Fang Fang; Mikhail Kovtun; Deqing Wu; Matt Duan; Konstantin Arbeev; Igor Akushevich; Alexander Kulminski; Irina Culminskaya; Ilya Zhbannikov; Arseniy Yashkin; Eric Stallard; Svetlana Ukraintseva
Journal:  Exp Gerontol       Date:  2017-10-26       Impact factor: 4.032

4.  IL6R haplotype rs4845625*T/rs4537545*C is a risk factor for simultaneously high CRP, LDL and ApoB levels.

Authors:  A A Arguinano; E Naderi; N C Ndiaye; M Stathopoulou; S Dadé; B Alizadeh; S Visvikis-Siest
Journal:  Genes Immun       Date:  2017-08-03       Impact factor: 2.676

5.  ADAM19: A Novel Target for Metabolic Syndrome in Humans and Mice.

Authors:  Lakshini Weerasekera; Caroline Rudnicka; Qing-Xiang Sang; Joanne E Curran; Matthew P Johnson; Eric K Moses; Harald H H Göring; John Blangero; Jana Hricova; Markus Schlaich; Vance B Matthews
Journal:  Mediators Inflamm       Date:  2017-02-07       Impact factor: 4.711

6.  BCL3-PVRL2-TOMM40 SNPs, gene-gene and gene-environment interactions on dyslipidemia.

Authors:  Liu Miao; Rui-Xing Yin; Shang-Ling Pan; Shuo Yang; De-Zhai Yang; Wei-Xiong Lin
Journal:  Sci Rep       Date:  2018-04-18       Impact factor: 4.379

7.  A TOMM40/APOE allele encoding APOE-E3 predicts high likelihood of late-onset Alzheimer's disease in autopsy cases.

Authors:  Selma M Soyal; Markus Kwik; Ognian Kalev; Stefan Lenz; Greta Zara; Peter Strasser; Wolfgang Patsch; Serge Weis
Journal:  Mol Genet Genomic Med       Date:  2020-05-30       Impact factor: 2.183

8.  Biothiols and oxidative stress markers and polymorphisms of TOMM40 and APOC1 genes in Alzheimer's disease patients.

Authors:  Michal Prendecki; Jolanta Florczak-Wyspianska; Marta Kowalska; Jan Ilkowski; Teresa Grzelak; Katarzyna Bialas; Malgorzata Wiszniewska; Wojciech Kozubski; Jolanta Dorszewska
Journal:  Oncotarget       Date:  2018-10-16

9.  Understanding the genetic architecture of the metabolically unhealthy normal weight and metabolically healthy obese phenotypes in a Korean population.

Authors:  Jae-Min Park; Da-Hyun Park; Youhyun Song; Jung Oh Kim; Ja-Eun Choi; Yu-Jin Kwon; Seong-Jin Kim; Ji-Won Lee; Kyung-Won Hong
Journal:  Sci Rep       Date:  2021-01-26       Impact factor: 4.379

10.  Impact of gender and age on the association of the BUD13-ZNF259 rs964184 polymorphism with coronary heart disease.

Authors:  Xiaofeng Xu; Yirun Li; Yi Huang; Huadan Ye; Liyuan Han; Huihui Ji; Xiaoyin Chen; Nan Wu; Danjie Jiang; Limin Xu; Dongjun Dai; Shiwei Duan; Xiaomin Chen
Journal:  Anatol J Cardiol       Date:  2018-01       Impact factor: 1.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.